Jie Xu,Fan Song,Huijue Lyu,Mikoto Kobayashi,Baozhen Zhang,Ziyu Zhao,Ye Hou,Xiaotao Wang,Yu Luan,Bei Jia,Lena Stasiak,Josiah Hiu-yuen Wong,Qixuan Wang,Qi Jin,Qiushi Jin,Yihao Fu,Hongbo Yang,Ross C. Hardison,Sinisa Dovat,Leonidas C. Platanias,Yarui Diao,Yue Yang,Tomoko Yamada,Aaron D. Viny,Ross L. Levine,David Claxton,James. R. Broach,Hong Zheng,Feng Yue

Abstract:Acute myeloid leukaemia (AML) represents a set of heterogeneous myeloid malignancies, and hallmarks include mutations in epigenetic modifiers, transcription factors and kinases1-5. The extent to which mutations in AML drive alterations in chromatin 3D structure and contribute to myeloid transformation is unclear. Here we use Hi-C and whole-genome sequencing to analyse 25 samples from patients with AML and 7 samples from healthy donors. Recurrent and subtype-specific alterations in A/B compartments, topologically associating domains and chromatin loops were identified. RNA sequencing, ATAC with sequencing and CUT&Tag for CTCF, H3K27ac and H3K27me3 in the same AML samples also revealed extensive and recurrent AML-specific promoter-enhancer and promoter-silencer loops. We validated the role of repressive loops on their target genes by CRISPR deletion and interference. Structural variation-induced enhancer-hijacking and silencer-hijacking events were further identified in AML samples. Hijacked enhancers play a part in AML cell growth, as demonstrated by CRISPR screening, whereas hijacked silencers have a downregulating role, as evidenced by CRISPR-interference-mediated de-repression. Finally, whole-genome bisulfite sequencing of 20 AML and normal samples revealed the delicate relationship between DNA methylation, CTCF binding and 3D genome structure. Treatment of AML cells with a DNA hypomethylating agent and triple knockdown of DNMT1, DNMT3A and DNMT3B enabled the manipulation of DNA methylation to revert 3D genome organization and gene expression. Overall, this study provides a resource for leukaemia studies and highlights the role of repressive loops and hijacked cis elements in human diseases.

Research Progress of Cohesin Complex Mutation in Acute Myeloid Leukemia

Characteristics of Cohesin Mutation in Acute Myeloid Leukemia and Its Clinical Significance

Cohesin mutations in acute myeloid leukemia

Research of gene mutation in acute myeloid leukemia: development and prospect

Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia

Chromatin Organization in Myelodysplastic Syndrome

Molecular basis of JAK2 H608Y and H608N mutations in the pathology of acute myeloid leukemia

Subunit-specific analysis of cohesin-mutant myeloid malignancies reveals distinct ontogeny and outcomes

Epigenetic Abnormalities in Acute Myeloid Leukemia and Leukemia Stem Cells.

Molecular Mutations and Their Cooccurrences in Cytogenetically Normal Acute Myeloid Leukemia

Research progress on molecular biomarkers of acute myeloid leukemia

[Molecular mechanisms in the development of acute myeloid leukemia]

Cytogenetics and genomics of acute myeloid leukemia

Current and emerging molecular and epigenetic disease entities in acute myeloid leukemia and a critical assessment of their therapeutic modalities

[Roles of CEBPA Mutation and Expression Abnormality in Acute Myeloid Leukemia - Review].

Advances in pathogenesis research and challenges in treatment development for acute myeloid leukemia

Role of Gene Mutations in Acute Myeloid Leukemia: A Review Article

Recent progress in AML with recurrent genetic abnormalities

[Progress in the Studies of Acute Myelogenous Leukemia Stem Cell].

Subtype-specific 3D Genome Alteration in Acute Myeloid Leukaemia

RAD21 mutations in acute myeloid leukemia